Similar articles

• Cholesterol and coronary heart disease. The importance of patient-specific attributable risk.

  Malenka DJ, Baron JA. Malenka DJ, et al. Arch Intern Med. 1988 Oct;148(10):2247-52. Arch Intern Med. 1988. PMID: 3178382
• Total mortality in cardiovascular risk factor intervention trials.

  Faergeman O. Faergeman O. Scand J Clin Lab Invest Suppl. 1990;199:7-13. Scand J Clin Lab Invest Suppl. 1990. PMID: 2191421 Review. No abstract available.
• Risk factors in the pathogenesis of coronary artery disease.

  Virmani R, Farb A, Burke AP. Virmani R, et al. Compr Ther. 1998 Oct;24(10):519-29. Compr Ther. 1998. PMID: 9801851 Review.
• [Coronary risk factors].

  Iglesias Cubero G, Rodríguez Reguero J, Barriales Alvarez V. Iglesias Cubero G, et al. Med Clin (Barc). 1995 Feb 4;104(4):142-7. Med Clin (Barc). 1995. PMID: 7898159 Review. Spanish. No abstract available.
• Coronary risk reduction in office practice.

  Luikart WM. Luikart WM. J La State Med Soc. 1974 Feb;126(2):51-7. J La State Med Soc. 1974. PMID: 4815661 No abstract available.